ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The University of Leeds has launched the Institute of Process Research & Development (iPRD) to help link university research capabilities more strongly to commercial needs in the pharmaceutical and fine chemicals sectors.
A major goal of the institute is to help improve the efficiency and environmental impact of production processes, says iPRD Director John Blacker. Blacker is also technical director at the drug company Piramal Healthcare in Huddersfield, U.K.
Supported by private companies and public funds, the institute will combine chemistry and engineering. "Global pharma can only meet increasingly tough demands from regulators for purity and reduced environmental footprint if it transitions to smarter, cleaner processes?which represent a combined chemical and engineering challenge," Blacker says.
Projects under way include the destruction of organic-aqueous waste, novel continuous processes, and nongenotoxic catalytic alkylations. The institute is also offering a master?s of science degree in chemical process R&D. Pharmaceutical and fine chemicals firms will teach course modules and provide industrial placements for degree-related research projects.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter